The results of the trial into a new type of smart drug given to Acute Myeloid Leukaemia patients show that GO treatment could improve the effectiveness of chemotherapy without excessively increasing side effects, according to the study.
The study, published in the Journal of Clinical Oncology, said that this may provide a potential lifeline for older AML patients who are often too frail to tolerate more intensive chemotherapy regimes.
More top news
An Atlantic frontal system brings rain across northwest Scotland and Northern Ireland overnight.
A memorial to honour the service of millions of men and women from Africa and the Caribbean during the two world wars has been unveiled.
South Africa's president often seems able to survive anything, writes John Ray - but a vote of no confidence held in secret may change that.